Annual report
9220.TEDINET S100TX94
Period2023-04-01 → 2024-03-31
Filed2024-06-28
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 145
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥10.4bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥9.6bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥9.2bn | 2021-04-01 → 2022-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥9.4bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥9.0bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥527m | 2023-04-01 → 2024-03-31 | Cons. | Operating income |
| Operating income | ¥544m | 2022-04-01 → 2023-03-31 | Cons. | Operating income |
| Ordinary income | ¥802m | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥737m | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥648m | 2021-04-01 → 2022-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥608m | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥532m | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥755m | 2023-04-01 → 2024-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥696m | 2022-04-01 → 2023-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥523m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥445m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥529m | 2021-04-01 → 2022-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥477m | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥486m | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥523m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss |
| Net income | ¥445m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss |
| Total assets | ¥9.5bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥9.0bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥7.7bn | at 2022-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥8.3bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥8.0bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥6.0bn | at 2024-03-31 | Cons. | Liabilities |
| Total liabilities | ¥6.0bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥3.5bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥3.0bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥2.0bn | at 2022-03-31d | Cons. | Net assets |
| Net assets / equity | ¥1.5bn | at 2021-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥632m | at 2020-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.4bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.4bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥2.2bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.2bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.6bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.7bn | at 2021-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥976m | at 2020-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥1.1bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥970m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥899m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.2bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥847m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥586m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥849m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥97m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥112m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥130m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥472m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥464m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥879m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥374m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥370m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥195.6 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥167.39 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥240.32 | 2021-04-01 → 2022-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥238.53 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥242.76 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥1,299.91 | at 2024-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,135.13 | at 2023-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥913.16 | at 2022-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥673.99 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥313.17 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 36.6% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.7% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 26.1% | at 2022-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 17.8% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 7.9% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 16.1% | 2023-04-01 → 2024-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 17.6% | 2022-04-01 → 2023-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 30.3% | 2021-04-01 → 2022-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 45.3% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 76.8% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 1,060 | at 2024-03-31 | Cons. | Number of employees |
| Employees | 1,011 | at 2023-03-31 | Cons. | Number of employees |
| Employees | 985 | at 2022-03-31d | Cons. | Number of employees |
| Employees | 999 | at 2021-03-31d | Cons. | Number of employees |
| Employees | 1,051 | at 2020-03-31d | Cons. | Number of employees |
| Revenue | ¥9.8bn | 2023-04-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥9.3bn | 2022-04-01 → 2023-03-31 | Standalone | Net sales |
| Revenue | ¥8.8bn | 2021-04-01 → 2022-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥8.1bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥7.6bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥497m | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Operating income | ¥523m | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Ordinary income | ¥767m | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥713m | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥578m | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥546m | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥581m | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥719m | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥705m | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Net income | ¥519m | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | ¥461m | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | ¥368m | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥502m | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥495m | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥9.3bn | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥8.9bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥7.5bn | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥7.8bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥7.2bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥5.9bn | at 2024-03-31 | Standalone | Liabilities |
| Total liabilities | ¥5.9bn | at 2023-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥3.4bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥2.9bn | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥1.9bn | at 2022-03-31d | Standalone | Net assets |
| Net assets / equity | ¥1.5bn | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥663m | at 2020-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥2.1bn | at 2024-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥2.2bn | at 2023-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥194.05 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥173.29 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥167.07 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥250.97 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥247.56 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥33 | 2023-04-01 → 2024-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥33 | 2022-04-01 → 2023-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥1,261.02 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,097.79 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥860.61 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥694.69 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥331.59 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 36.3% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.2% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 25.2% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 19.5% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 9.2% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 16.5% | 2023-04-01 → 2024-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 19.1% | 2022-04-01 → 2023-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 21.5% | 2021-04-01 → 2022-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 45.8% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 73.3% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 2,676,000 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,676,000 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,200,000 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,200,000 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 200 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 979 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 952 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 938 | at 2022-03-31d | Standalone | Number of employees |
| Employees | 888 | at 2021-03-31d | Standalone | Number of employees |
| Employees | 840 | at 2020-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 44
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2023-04-01 → 2024-03-31 | ¥11m |
| Reconciling Itemsreconciling | segment assets | at 2024-03-31 | ¥2.9bn |
| Nursing Care Businessreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥637m |
| Nursing Care Businessreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥327m |
| Nursing Care Businessreportable segment | employees | at 2024-03-31 | 743 pure |
| Nursing Care Businessreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥6.0bn |
| Nursing Care Businessreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥6.0bn |
| Nursing Care Businessreportable segment | segment assets | at 2024-03-31 | ¥5.3bn |
| Nursing Care Businessreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥194m |
| Nursing Care Equipment Businessreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥48m |
| Nursing Care Equipment Businessreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥26m |
| Nursing Care Equipment Businessreportable segment | employees | at 2024-03-31 | 262 pure |
| Nursing Care Equipment Businessreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥4.4bn |
| Nursing Care Equipment Businessreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥4.4bn |
| Nursing Care Equipment Businessreportable segment | segment assets | at 2024-03-31 | ¥1.3bn |
| Nursing Care Equipment Businessreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥333m |
| Total Of Reportable Segments And Otherssegment total | capex | 2023-04-01 → 2024-03-31 | ¥685m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2023-04-01 → 2024-03-31 | ¥352m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2024-03-31 | ¥10.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2024-03-31 | ¥10.4bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2024-03-31 | ¥6.6bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2024-03-31 | ¥527m |
| Reconciling Itemsreconciling | capex | 2022-04-01 → 2023-03-31 | ¥3m |
| Reconciling Itemsreconciling | segment assets | at 2023-03-31 | ¥2.9bn |
| Nursing Care Businessreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥761m |
| Nursing Care Businessreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥283m |
| Nursing Care Businessreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥5.5bn |
| Nursing Care Businessreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥5.5bn |
| Nursing Care Businessreportable segment | segment assets | at 2023-03-31 | ¥5.0bn |
| Nursing Care Businessreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥168m |
| Nursing Care Equipment Businessreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥14m |
| Nursing Care Equipment Businessreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥24m |
| Nursing Care Equipment Businessreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥4.1bn |
| Nursing Care Equipment Businessreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥4.1bn |
| Nursing Care Equipment Businessreportable segment | segment assets | at 2023-03-31 | ¥1.1bn |
| Nursing Care Equipment Businessreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥376m |
| Total Of Reportable Segments And Otherssegment total | capex | 2022-04-01 → 2023-03-31 | ¥775m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2022-04-01 → 2023-03-31 | ¥307m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2023-03-31 | ¥9.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2023-03-31 | ¥9.6bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2023-03-31 | ¥6.2bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2023-03-31 | ¥544m |
| Nursing Care Businessreportable segment | employees | at 2024-03-31 | 665 pure |
| Nursing Care Equipment Businessreportable segment | employees | at 2024-03-31 | 259 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,374
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of voting rights issued shares voting rights | CurrentYearInstant | 26746 | |
| Total amount of dividends dividends of surplus | FilingDateInstant_Row1Member | 34788000 | JPY |
| Dividend per share dividends of surplus | FilingDateInstant_Row1Member | 13 | |
| Total amount of dividends dividends of surplus | FilingDateInstant_Row2Member | 53520000 | JPY |
| Dividend per share dividends of surplus | FilingDateInstant_Row2Member | 20 | |
| Number of male directors and other officers | FilingDateInstant | 7 | |
| Number of female directors and other officers | FilingDateInstant | 2 | |
| Ratio of female directors and other officers | FilingDateInstant | 0.222 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E37523-000YanagisawaHidekiMember | 365000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E37523-000YanagisawaMihoMember | 165000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E37523-000YodaDailiMember | 100 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E37523-000NinomiyaOsamuMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E37523-000TeraoFumitakaMember | 41400 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E37523-000SasakiHideoMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E37523-000KiuchiHitoshiMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E37523-000IchimiyaNahomiMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E37523-000ShimakataTakuroMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant | 571500 | |
| Audit fees reporting company | Prior1YearDuration | 39000000 | JPY |
| Non audit fees reporting company | Prior1YearDuration | － | JPY |
| Audit fees reporting company | CurrentYearDuration | 35000000 | JPY |
| Non audit fees reporting company | CurrentYearDuration | － | JPY |
| Audit fees consolidated subsidiaries | Prior1YearDuration | － | JPY |
| Non audit fees consolidated subsidiaries | Prior1YearDuration | － | JPY |
| Audit fees consolidated subsidiaries | CurrentYearDuration | － | JPY |
| Non audit fees consolidated subsidiaries | CurrentYearDuration | － | JPY |
| Audit fees total | Prior1YearDuration | 39000000 | JPY |
| Non audit fees total | Prior1YearDuration | － | JPY |
| Audit fees total | CurrentYearDuration | 35000000 | JPY |
| Non audit fees total | CurrentYearDuration | － | JPY |
| Total amount of remuneration etc remuneration etc by category of directors and other officers | CurrentYearDuration_DirectorsExcludingAuditAndSupervisoryCommitteeMembersAndOutsideDirectorsMember | 51900000 | JPY |
| Base remuneration remuneration etc by category of directors and other officers | CurrentYearDuration_DirectorsExcludingAuditAndSupervisoryCommitteeMembersAndOutsideDirectorsMember | 51900000 | JPY |
| Share option remuneration etc by category of directors and other officers | CurrentYearDuration_DirectorsExcludingAuditAndSupervisoryCommitteeMembersAndOutsideDirectorsMember | － | JPY |
| Bonus remuneration etc by category of directors and other officers | CurrentYearDuration_DirectorsExcludingAuditAndSupervisoryCommitteeMembersAndOutsideDirectorsMember | － | JPY |
| Retirement benefits remuneration etc by category of directors and other officers | CurrentYearDuration_DirectorsExcludingAuditAndSupervisoryCommitteeMembersAndOutsideDirectorsMember | － | JPY |
| Number of directors and other officers remuneration etc by category of directors and other officers | CurrentYearDuration_DirectorsExcludingAuditAndSupervisoryCommitteeMembersAndOutsideDirectorsMember | 6 | |
| Total amount of remuneration etc remuneration etc by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E37523-000DirectorsAuditAndSupervisoryCommitteeMembersMember | 6000000 | JPY |
| Base remuneration remuneration etc by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E37523-000DirectorsAuditAndSupervisoryCommitteeMembersMember | 6000000 | JPY |
| Share option remuneration etc by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E37523-000DirectorsAuditAndSupervisoryCommitteeMembersMember | － | JPY |
| Bonus remuneration etc by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E37523-000DirectorsAuditAndSupervisoryCommitteeMembersMember | － | JPY |
| Retirement benefits remuneration etc by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E37523-000DirectorsAuditAndSupervisoryCommitteeMembersMember | － | JPY |
| Number of directors and other officers remuneration etc by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E37523-000DirectorsAuditAndSupervisoryCommitteeMembersMember | 1 | |
| Total amount of remuneration etc remuneration etc by category of directors and other officers | CurrentYearDuration_OutsideDirectorsAndOtherOfficersMember | 9600000 | JPY |
| Base remuneration remuneration etc by category of directors and other officers | CurrentYearDuration_OutsideDirectorsAndOtherOfficersMember | 9600000 | JPY |
| Share option remuneration etc by category of directors and other officers | CurrentYearDuration_OutsideDirectorsAndOtherOfficersMember | － | JPY |
| Bonus remuneration etc by category of directors and other officers | CurrentYearDuration_OutsideDirectorsAndOtherOfficersMember | － | JPY |
| Retirement benefits remuneration etc by category of directors and other officers | CurrentYearDuration_OutsideDirectorsAndOtherOfficersMember | － | JPY |
| Number of directors and other officers remuneration etc by category of directors and other officers | CurrentYearDuration_OutsideDirectorsAndOtherOfficersMember | 3 | |
| Number of issues shares not listed investment shares held for pure investment reporting company | CurrentYearInstant | － | |
| Book value equity securities not listed investment equity securities held for pure investment reporting company | CurrentYearInstant | － | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |